- Home
- SACH vs GRCE Comparison
SACH vs GRCE Comparison
Compare SACH & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SACH
- GRCE
- Stock Information
- Founded
- SACH 2010
- GRCE 2002
- Country
- SACH United States
- GRCE United States
- Employees
- SACH N/A
- GRCE N/A
- Industry
- SACH Real Estate Investment Trusts
- GRCE
- Sector
- SACH Real Estate
- GRCE
- Exchange
- SACH Nasdaq
- GRCE NYSE
- Market Cap
- SACH 46.7M
- GRCE 40.0M
- IPO Year
- SACH 2017
- GRCE N/A
- Fundamental
- Price
- SACH $1.09
- GRCE $3.00
- Analyst Decision
- SACH Hold
- GRCE Strong Buy
- Analyst Count
- SACH 3
- GRCE 1
- Target Price
- SACH $2.25
- GRCE $12.00
- AVG Volume (30 Days)
- SACH 216.2K
- GRCE 40.7K
- Earning Date
- SACH 08-13-2025
- GRCE 08-15-2025
- Dividend Yield
- SACH 18.61%
- GRCE N/A
- EPS Growth
- SACH N/A
- GRCE N/A
- EPS
- SACH N/A
- GRCE N/A
- Revenue
- SACH N/A
- GRCE N/A
- Revenue This Year
- SACH N/A
- GRCE N/A
- Revenue Next Year
- SACH $4.52
- GRCE N/A
- P/E Ratio
- SACH N/A
- GRCE N/A
- Revenue Growth
- SACH N/A
- GRCE N/A
- 52 Week Low
- SACH $0.80
- GRCE $1.75
- 52 Week High
- SACH $3.07
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- SACH 52.20
- GRCE N/A
- Support Level
- SACH $1.03
- GRCE N/A
- Resistance Level
- SACH $1.11
- GRCE N/A
- Average True Range (ATR)
- SACH 0.06
- GRCE 0.00
- MACD
- SACH -0.00
- GRCE 0.00
- Stochastic Oscillator
- SACH 44.07
- GRCE 0.00
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.